Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASTEROID
NCT00240318Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Nov 2002
- Primary completion
- Nov 2005
- Modality
- Orthosteric Ligands
- Countries
- 8
01
Overview
A Phase 3 trial of rosuvastatin in coronary artery disease (CAD), sponsored by AstraZeneca. Started Nov 2002; status: completed.
02
Drugs
rosuvastatin
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00240318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00240318.